Arbutus alleges that Moderna’s COVID-19 vaccine infringes on patents protecting its lipid nanoparticle delivery technology.

BioNTech SE BNTX has filed a patent infringement lawsuit against Moderna Inc. MRNA, alleging that Moderna's next-generation COVID-19 vaccine, mNEXSPIKE, relies on proprietary technology developed and ...

Moderna (MRNA) faces a lawsuit in the U.S. for allegedly infringing patent rights related to the COVID-19 shot developed by ...

For our latest UPC update, we report on recent developments, including an expansion of GSK’s COVID-19 vaccine claim against Moderna and a ruling that offers hope for litigation insurance. A new claim ...

BioNTech has filed a lawsuit against Moderna in a Delaware federal court over allegations of patent infringement related to ...

Moderna (NasdaqGS:MRNA) is involved in an ongoing patent infringement case related to its COVID-19 vaccine, with a recent court ruling addressing claims from Arbutus Biopharma and Genevant. The ...

BioNTech has filed a lawsuit against Moderna in a Delaware federal court, claiming infringement on a patent related to their COVID-19 vaccine technology. Moderna's vaccine, mNEXSPIKE, allegedly ...

The Biden administration, in a major decision Wednesday, said it would support easing patent rules on COVID-19 vaccines after intense internal debate and strong pushback from American drugmakers, ...

The current reality is one of verified, world-class innovation that positions Uganda as a hub for advanced biotechnology ...

Moderna wants to reportedly leave U.S. government scientists off a patent for its COVID-19 vaccine. Moderna and the National Institutes of Health (NIH) worked together to create the mRNA coronavirus ...